XML 37 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 129 $ 111
Accounts receivable, net 1,315 1,373
Accrued unbilled revenues 853 1,105
Inventories 711 803
Regulatory assets 611 1,059 [1]
Derivative instruments 104 279
Prepaid taxes 52 54
Prepayments and other 294 360
Total current assets 4,069 5,144
Property, plant and equipment, net 51,642 48,253
Other assets    
Nuclear decommissioning fund and other investments 3,599 3,234
Regulatory assets 2,798 2,871 [1]
Derivative instruments 76 93
Operating lease right-of-use assets 1,217 1,204
Other 678 389
Total other assets 8,368 7,791
Total assets 64,079 61,188 Close
Current liabilities    
Current portion of long-term debt 552 1,151
Short-term debt 785 813
Accounts payable 1,668 1,804
Regulatory liabilities [2] 528 418
Taxes accrued 557 569
Accrued interest 251 217
Dividends payable 289 268
Derivative instruments 74 76
Operating Lease, Liability, Current 226 217
Other 722 545
Total current liabilities 5,652 6,078
Deferred credits and other liabilities    
Deferred income taxes 4,885 4,756
Deferred investment tax credits 60 48
Regulatory liabilities [2] 5,827 5,569
Asset retirement obligations 3,218 3,380
Derivative instruments 86 113
Customer advances 167 181
Pension and employee benefit obligations 469 390
Operating lease liabilities 1,038 1,038
Other 148 147
Total deferred credits and other liabilities 15,898 15,622
Commitments and contingencies
Capitalization    
Long-term debt 24,913 22,813
Common stock — 1,000,000,000 shares authorized of $2.50 par value; 554,941,703 and 549,578,018 shares outstanding at Dec. 31, 2023 and Dec. 31, 2022, respectively $ 1,387 $ 1,374
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock, par value (in dollars per share) $ 2.50 $ 2.50
Common Stock, Shares, Outstanding 554,941,703 549,578,018
Additional paid in capital $ 8,465 $ 8,155
Retained earnings 7,858 7,239
Accumulated other comprehensive loss (94) (93)
Total common stockholders’ equity 17,616 16,675 Close
Total liabilities and equity $ 64,079 $ 61,188
[1] Prior period amounts have been reclassified to conform with current year presentation.
[2] Revenue subject to refund of $187 million and $67 million for 2023 and 2022, respectively, is included in other current liabilities.